Cyndi Lauper On Cosentyx Commercial: Her Inspiring Journey With Plaque Psoriasis And What It Means For Patients
Cyndi Lauper, the Grammy, Emmy, and Tony Award-winning pop icon behind timeless hits like "Girls Just Want to Have Fun" and "Time After Time," shocked and inspired millions when she became the public face of the Cosentyx (secukinumab) advertising campaign. For decades, Lauper struggled privately with moderate-to-severe plaque psoriasis, a chronic, painful autoimmune condition that causes raised, red, scaly patches on the skin. Before finding an effective treatment, the physical pain and emotional toll of the disease threatened her ability to perform on stage, wear her signature vibrant outfits, and live her life with her trademark confidence.
Her partnership with Novartis, the pharmaceutical company behind Cosentyx, began in 2015. Through various television commercials, digital media campaigns, and the "See Me" advocacy initiative, Lauper sought to shed light on a condition that affects over 8 million Americans. By sharing her personal battle with psoriasis, she shifted the narrative from silent suffering to empowered action. The commercials showed her not as a victim of her illness, but as a thriving artist who reclaimed her life, her wardrobe, and her skin.
The cultural impact of her involvement cannot be overstated. Prior to Lauper's campaign, pharmaceutical advertisements for psoriasis often featured anonymous actors in sterile, clinical settings, which felt disconnected from the lived experience of patients. Having a household name openly discuss the physical pain of her scales, the embarrassment of shedding skin on tour buses, and her desperate search for relief humanized the condition. It gave countless viewers the courage to stop hiding their skin and initiate open, honest conversations with their dermatologists.
Understanding Cosentyx: The Science Behind the Medication
To understand why Cyndi Lauper's endorsement of Cosentyx is so significant, it is essential to look at what the medication actually is and how it works. Cosentyx (secukinumab) is a prescription biologic medication approved for the treatment of moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. Unlike traditional topical creams or systemic oral medications that broadly suppress the entire immune system, Cosentyx is a highly targeted monoclonal antibody designed to address the root biological cause of the disease.
The medication works by targeting and blocking a specific protein in the body called interleukin-17A (IL-17A). This protein is a cytokine that plays a central role in driving the inflammation and rapid skin cell overproduction characteristic of psoriasis. In healthy bodies, skin cells grow and shed over the course of a month; in psoriasis patients, this process happens in just a few days, leading to the buildup of painful scales. By binding directly to IL-17A, Cosentyx stops this inflammatory cascade in its tracks, allowing the skin to heal and return to a normal growth cycle.
Administered via a pre-filled syringe or an easy-to-use Sensoready autoinjector pen, Cosentyx is typically initiated with weekly starter doses for the first five weeks, followed by monthly maintenance injections. For active patients like Lauper, whose careers demand constant travel, physical stamina, and public appearances, the convenience of at-home monthly dosing represents a massive leap forward in managing chronic illness without disrupting daily life or creative pursuits.
Comparing Cosentyx to Other Psoriasis Treatments
When choosing a biologic treatment for moderate-to-severe plaque psoriasis, patients and healthcare providers must weigh factors such as efficacy, dosing frequency, and the specific biological pathway targeted. The table below compares Cosentyx with other prominent biologic therapies on the market today.
| Biologic Brand Name | Active Ingredient | Target Pathway | Standard Maintenance Dosing | Primary Pros | Primary Cons |
|---|---|---|---|---|---|
| Cosentyx | Secukinumab | IL-17A Inhibitor | Every 4 weeks (subcutaneous injection) | Rapid skin clearance; highly effective for scalp, nail, and palm psoriasis | Risk of inflammatory bowel disease (IBD) flares; frequent starter doses |
| Humira | Adalimumab | TNF-alpha Inhibitor | Every 2 weeks (subcutaneous injection) | Long track record of safety; approved for a wide variety of autoimmune conditions | More frequent injections; slightly lower average skin clearance rates than newer IL-17/23 inhibitors |
| Stelara | Ustekinumab | IL-12/23 Inhibitor | Every 12 weeks (subcutaneous injection) | Highly convenient dosing schedule (only 4 times a year) | Slower onset of action compared to IL-17 inhibitors |
| Tremfya | Guselkumab | IL-23 Inhibitor | Every 8 weeks (subcutaneous injection) | Exceptionally long-lasting skin clearance; low injection frequency | Newer drug with less long-term real-world data than older TNF-alpha blockers |
While older biologics like Humira target TNF-alpha, newer generation biologics like Cosentyx and Tremfya target more specific interleukins, resulting in higher percentages of patients achieving completely clear skin (PASI 90 or PASI 100). Every patient's immune system is unique, which is why a dermatologist will evaluate previous treatment failures, lifestyle preferences, and co-existing conditions (like joint pain or gut health issues) before selecting the optimal biologic.
Cyndi Lauper, 72, Curses Out Heckler During Concert - Parade
The Power of Celebrity Advocacy in Modern Healthcare Marketing
The "Cyndi Lauper on Cosentyx commercial" phenomenon represents a masterclass in modern healthcare marketing. For decades, direct-to-consumer (DTC) pharmaceutical advertising was criticized for being overly transactional or clinical. The collaboration between Lauper and Novartis changed this dynamic by focusing on authentic, unfiltered storytelling. Viewers were not just hearing a list of complex side effects; they were watching a beloved pop icon talk about the raw embarrassment of wearing long sleeves in the dead of summer to hide her lesions.
This level of transparency is incredibly powerful in reducing the deep-seated stigma associated with psoriasis. Because psoriasis is highly visible, many sufferers experience severe anxiety, clinical depression, and social isolation. Seeing someone as expressive, fashionable, and bold as Cyndi Lauper reclaim her identity sends a powerful psychological message: your skin condition does not define your worth or your beauty, and you do not have to hide.
However, celebrity healthcare endorsements also come with a heavy responsibility for balanced information. While Lauper’s success story with Cosentyx is genuine, biologic treatments are not one-size-fits-all solutions. The commercials must carefully balance the emotional narrative of skin clearance with clinical realities, including potential risks of serious infections, inflammatory bowel disease flares, and the necessity of regular laboratory monitoring. Responsible marketing ensures that patients are inspired to seek help while remaining fully informed of the risks involved.
How to Determine If Cosentyx Is Right for You
If you have watched Cyndi Lauper on the Cosentyx commercial and felt a spark of hope for your own skin journey, the first step is to consult a board-certified dermatologist. Biologics are typically reserved for patients with moderate-to-severe plaque psoriasis who have not responded well to, or cannot tolerate, first-line treatments like topical steroids, phototherapy (light therapy), or traditional systemic drugs like methotrexate.
Your dermatologist will perform a thorough evaluation, which includes measuring your Psoriasis Area and Severity Index (PASI) score and assessing how much the condition impacts your daily life and mental health. Because Cosentyx mildly suppresses a portion of your immune system, you will need to undergo screening for latent tuberculosis (TB) and other active chronic infections before starting treatment. Your doctor will also review your medical history to ensure you do not have pre-existing inflammatory bowel diseases, such as Crohn's disease or ulcerative colitis, which could be worsened by blocking the IL-17 pathway.
Preparing for your specialist consultation is straightforward. Compile a complete history of your previous psoriasis treatments, note how long you used them, and detail any side effects you experienced. Be prepared to discuss how psoriasis affects your daily activities, sleep, and emotional well-being. Asking targeted questions about Cosentyx—such as its long-term safety profile, manufacturer copay assistance programs, and the expected timeline for clearance—will help you make an informed, collaborative decision with your medical team.
Frequently Asked Questions
Why did Cyndi Lauper decide to do the Cosentyx commercials?
Cyndi Lauper decided to partner with Novartis for the Cosentyx commercials to raise public awareness about moderate-to-severe plaque psoriasis and to combat the deep social stigma associated with the condition. Having suffered from severe flares that left her feeling exhausted, covered in painful scales, and depressed, she wanted to use her platform to show other sufferers that they do not have to hide or suffer in silence.
Is Cyndi Lauper still taking Cosentyx?
While specific current personal medical details remain private, Cyndi Lauper has consistently advocated for finding a treatment plan that works and sticking with it. She has credited Cosentyx with helping her regain control of her skin and physical comfort, allowing her to perform on stage and wear her signature outfits without pain or self-consciousness.
What are the most common side effects of Cosentyx?
The most common side effects of Cosentyx include cold symptoms (nasopharyngitis), upper respiratory tract infections, diarrhea, and mild skin reactions at the injection site. Because Cosentyx targets the immune system, it can lower your body's ability to fight off infections. Patients should report any signs of infection, fever, or worsening gut symptoms to their doctor immediately.
How long does it take for Cosentyx to start working?
Many patients begin to see noticeable improvements in their skin within the first 2 to 4 weeks of starting Cosentyx, with significant clearance achieved by week 12. Clinical trials show that a high percentage of patients achieve 75% to 100% skin clearance after completing the initial weekly loading doses and transitioning to monthly maintenance therapy.
Does health insurance cover Cosentyx?
Yes, most commercial health insurance plans and Medicare prescription drug plans provide coverage for Cosentyx, though prior authorization from a dermatologist is usually required. Additionally, Novartis offers a Cosentyx Connect Copay Program for commercially insured patients, which can reduce out-of-pocket medication costs to as low as $0 per month.
Take Control of Your Skin Journey Today
You do not have to let moderate-to-severe plaque psoriasis dictate what you wear, how you feel, or how you live your life. Just like Cyndi Lauper reclaimed her stage, you can reclaim your confidence and skin health. Schedule an appointment with a board-certified dermatologist today to discuss whether advanced biologic treatments like Cosentyx are the right choice for your unique medical profile.
